SELENOP and endometrial carcinoma: As shown in Figure 7, IHC images revealed that CDKN2A, SELENOP, and TRPC1 were expressed at higher levels in endometrial carcinoma tissues compared to normal endometrial tissues, consistent with their mRNA upregulation in high-risk patients.